Orlando, FL -- (SBWIRE) -- 10/04/2013 -- Hot Stock Profits provides investors and traders with valuable trading tools and content as well as micro-cap stock alerts via eMail and text messages. To Join Our Text Message Alerts Service Just Text The Word Stocks To 555888 From Your Cell Phone. Our Focus Today Is On Celldex Therapeutics, Inc. (NASDAQ:CLDX), Health Management Associates, Inc. (NYSE:HMA).
Celldex Therapeutics, Inc. (NASDAQ:CLDX) shares declined 8.04% to $33.76. The company announced that Anthony Marucci, President and Chief Executive Officer, and Tibor Keler, PhD, Senior Vice President and Chief Scientific Officer, presented at the Leerink Swann Rare Disease Roundtable on Wednesday, October 2, 2013 at 3:20 p.m. ET at the Le Parker Meridien in New York City.
Additionally, Equities research analysts at Leerink Swann boosted their price target on shares of CLDX to $45.00 in a research note issued to investors on Sept. 23.
Are investors worried about the recent updates with CLDX? Find out with a free trend analysis HERE
Health Management Associates, Inc. (NYSE:HMA) shares gained 0.15% to $12.93. The company on Sept. 25 announced that its newly constituted Board of Directors is in the process of evaluating HMA's previously announced merger with Community Health Systems, Inc. (NYSE: CYH) ("CHS") consistent with the terms of the merger agreement. In connection with its review, the Board has retained independent financial advisors, Lazard Frères & Co. LLC and UBS Securities LLC, legal counsel, Paul, Weiss, Rifkind, Wharton & Garrison LLP and financial operating and compliance consultant Alvarez & Marsal Healthcare Industry Group, LLC.
Is HMA going to continue its rally or drop like a rock? Find out with a free trend analysis HERE
Join Our Mobile SMS Alerts By Texting Stocks To 555888
HotStockProfits.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
Disclosure: HotStockProfits.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit HotStockProfits.com website, for complete risks and disclosures.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)